DE602006009840D1 - Verwendung von prolactin in der prophylaktischen krebstherapie - Google Patents

Verwendung von prolactin in der prophylaktischen krebstherapie

Info

Publication number
DE602006009840D1
DE602006009840D1 DE602006009840T DE602006009840T DE602006009840D1 DE 602006009840 D1 DE602006009840 D1 DE 602006009840D1 DE 602006009840 T DE602006009840 T DE 602006009840T DE 602006009840 T DE602006009840 T DE 602006009840T DE 602006009840 D1 DE602006009840 D1 DE 602006009840D1
Authority
DE
Germany
Prior art keywords
prolactin
cancer therapy
prophylactic cancer
prophylactic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009840T
Other languages
English (en)
Inventor
Wen Yuan Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONCOLIX, INC., US
Original Assignee
GHC Research Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GHC Research Development Corp filed Critical GHC Research Development Corp
Publication of DE602006009840D1 publication Critical patent/DE602006009840D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2257—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602006009840T 2005-10-20 2006-10-19 Verwendung von prolactin in der prophylaktischen krebstherapie Active DE602006009840D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72829705P 2005-10-20 2005-10-20
US76389206P 2006-02-01 2006-02-01
PCT/US2006/040806 WO2007047803A2 (en) 2005-10-20 2006-10-19 Use of prolactin in the prophylactic treatment of cancer

Publications (1)

Publication Number Publication Date
DE602006009840D1 true DE602006009840D1 (de) 2009-11-26

Family

ID=37963261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006009840T Active DE602006009840D1 (de) 2005-10-20 2006-10-19 Verwendung von prolactin in der prophylaktischen krebstherapie

Country Status (6)

Country Link
US (1) US20100041598A1 (de)
EP (1) EP1959985B1 (de)
AT (1) ATE445408T1 (de)
CA (1) CA2626785A1 (de)
DE (1) DE602006009840D1 (de)
WO (1) WO2007047803A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100475757C (zh) 2000-02-01 2009-04-08 斯特维亚私人有限公司 用于饮食补充或用于制备治疗非胰岛素依赖性糖尿病、高血压和/或代谢综合征的药物的物质
EP2531211A4 (de) * 2010-02-03 2013-10-23 Orbis Health Solutions Llc Verfahren zur sensibilisierung von zellen für eine krebstherapie
EP2526961A1 (de) * 2011-05-26 2012-11-28 Mario Sargentini Behandlung oder Linderung einige neuroendokrine Erkrankungen bei männlichen mit Hilfe von Prolaktin
EP3996737A4 (de) * 2019-07-09 2023-06-14 Lateral Ip Pty Ltd Peptide und ihre verwendungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080728A (en) * 1996-07-16 2000-06-27 Mixson; A. James Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
AU4308699A (en) * 1998-05-12 1999-11-29 Greenville Hospital System Use of anti-prolactin agents to treat proliferative conditions
US20080132445A1 (en) * 2002-09-25 2008-06-05 Garvan Institute Of Medical Reserach Method for Inducing Mammary Epithelial Cell Differentiation

Also Published As

Publication number Publication date
EP1959985A2 (de) 2008-08-27
EP1959985B1 (de) 2009-10-14
WO2007047803A3 (en) 2007-09-07
WO2007047803A2 (en) 2007-04-26
CA2626785A1 (en) 2007-04-26
US20100041598A1 (en) 2010-02-18
ATE445408T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
IL258880A (en) Compounds of diarylhydantoin
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
EA200701995A1 (ru) Способы уменьшения кальцификации
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
UA89226C2 (en) Imidazole compounds
MY149606A (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
NO20055741D0 (no) Nye kjemiske forbindelser
EA201290356A1 (ru) Композиции для лечения тошноты и рвоты центрального происхождения
TW200716088A (en) Formulations and methods for treating amyloidosis
EA201170447A1 (ru) Производные изохинолинона в качестве антагонистов nk3
ATE445408T1 (de) Verwendung von prolactin in der prophylaktischen krebstherapie
DE602005015329D1 (de) Rutheniumkomplexe zur krebsbehandlung
EA200702136A1 (ru) Композиции станнсопорфина и их применение
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE411313T1 (de) Neue makrocyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 1959985

Country of ref document: EP

Owner name: ONCOLIX, INC., US

Free format text: FORMER OWNER: GHC RESEARCH DEVELOPMENT CORPORATION, GREENVILLE, US

Effective date: 20110704

R082 Change of representative

Ref document number: 1959985

Country of ref document: EP

Representative=s name: DF-MP, 80333 MUENCHEN, DE